Articles

Opinion: Top 2 takeaways from UBS Global Healthcare Conference

June 16, 2017

The conference raised important points about unregulated growth opportunities and new pharmacy arena players.

Opinion: Top 2 takeaways from Asembia Specialty Pharmacy Summit

May 20, 2017

The conference raised important points about value-based contracts and the specialty pharmacy space.

Value-based care takes over J.P. Morgan Healthcare Conference 2017

January 23, 2017

Is the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference.

Three issues to watch at the J.P. Morgan Healthcare Conference 2017

January 03, 2017

This year’s J.P. Morgan Healthcare Conference will address some of the biggest managed care trends, including next-gen at-risk contracts and access to therapy as cancer trends towards a chronic condition.

What billions in lost pharma revenue means for managed care

December 12, 2016

Pharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend.

Real-world results determine value-based price for specialty drugs

July 01, 2016

In an era when adherence to specialty pharmaceuticals is disturbingly low, value-based pricing needs real-world results, not single-arm accelerated trials.